BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11730671)

  • 1. Choroidal melanoma metastatic to the contralateral choroid.
    Singh AD; Shields JA; Shields CL; Sato T
    Am J Ophthalmol; 2001 Dec; 132(6):941-3. PubMed ID: 11730671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation.
    Anteby I; Axer-Siegel R; Pe'er J
    Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
    Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
    Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal melanoma suspect. Conservative treatment and evolution. Case report.
    Zemba M; Malciolu RA
    Rom J Ophthalmol; 2016; 60(4):264-269. PubMed ID: 29450360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral primary choroidal melanoma treated with bilateral plaque radiotherapy: a report of three cases.
    Furuta M; Shields CL; Uysal Y; Shields JA
    Eur J Ophthalmol; 2006; 16(6):879-82. PubMed ID: 17191200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis of choroidal melanoma to the contralateral choroid, orbit, and eyelid.
    Shields JA; Shields CL; Shakin EP; Kobetz LE
    Br J Ophthalmol; 1988 Jun; 72(6):456-60. PubMed ID: 3390423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
    Gündüz K; Shields CL; Shields JA; Cater J; Brady L
    Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium applicators in the treatment of choroidal melanomas.
    Van Hijfte R; Verbraeken H; De Laey JJ
    Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.
    Shields CL; Sioufi K; Srinivasan A; Di Nicola M; Masoomian B; Barna LE; Bekerman VP; Say EAT; Mashayekhi A; Emrich J; Komarnicky L; Shields JA
    JAMA Ophthalmol; 2018 Dec; 136(12):1325-1333. PubMed ID: 30267070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?
    Chiam PJ; Coupland SE; Kalirai H; Groenewald C; Heimann H; Damato BE
    Br J Ophthalmol; 2014 Jul; 98(7):967-71. PubMed ID: 24518077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
    Masoomian B; Mashayekhi A; Shields JA; Shields CL
    Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy].
    Bogdali A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(3):169-72. PubMed ID: 26999940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-contiguous recurrence or secondary choroidal melanoma following plaque radiotherapy.
    Maia M; Pieramici DJ; Au Eong KG; Schachat AP; Rodrigues EB; Green WR
    Clin Exp Ophthalmol; 2007; 35(7):657-60. PubMed ID: 17894687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic atrophy and choroidal melanoma located 3 mm apart.
    Geirsdottir A; Hungerford J; Stefansson E; Jonasson F; Helgadottir G; Sigurdsson H
    Acta Ophthalmol; 2008 Aug; 86(5):584-5. PubMed ID: 18221498
    [No Abstract]   [Full Text] [Related]  

  • 19. Fungal granuloma following ruthenium plaque radiotherapy of a choroidal melanoma.
    Okera S; Dodd T; Selva D; Muecke J
    Clin Exp Ophthalmol; 2003 Apr; 31(2):159-61. PubMed ID: 12648052
    [No Abstract]   [Full Text] [Related]  

  • 20. Bilateral breast metastases from choroidal melanoma.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
    Am J Ophthalmol; 2001 Apr; 131(4):521-3. PubMed ID: 11292427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.